A novel therapeutic strategy for aortic dissection
Description: Aortic dissection (AD) is a fatal disease that occurs suddenly without preceding clinical signs or symptoms. In the current study, we demonstrated that rapamycin-sensitive mTOR pathway governs cell proliferation of aortic wall cells in response to AD-inducing stimuli. Suppression of mTOR pathway by rapamycin completely prevented the AD development and progression after AD onset. Mechanistically, rapamycin treatment resulted in the inhibition of cell proliferation, and activation Stat3 in aortic wall medial smooth muscle cells. In turn, activation of smooth muscle Stat3 protected aortic tissue partly by activating adventitial fibroblast and deposition of collagen fibers. Deciphering the molecular mechanism of AD would be essential in developing the diagnostic and therapeutic strategies for this fatal disease.
Amount: ¥17,420,000
Funding type: research
Funder scheme: Grant-in-Aid for Scientific Research (B)
Start date: 2016-04-01
End date: 2019-03-31
Investigator: hiroki AOKI (lead)
Institution: Kurume University
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Funded outputs count: 14
Funder award ID: 16H05428
OpenAlex ID: G5306078314
